| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.21 | 0.2 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.2 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.2 |